| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |